miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway
Ke Lijuan,
Chen Yanping,
Li Yiying,
Chen Zheng,
He Yihui,
Liu Jiahua,
Zhuang Yingfeng
Affiliations
Ke Lijuan
Department of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People’s Republic of China
Chen Yanping
Department of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People’s Republic of China
Li Yiying
Department of Gynecology and Obstetrics, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital South Branch, No. 516 Jinrong South Street, Fuzhou, Fujian 350028, People’s Republic of China
Chen Zheng
Department of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People’s Republic of China
He Yihui
Department of Pathology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People’s Republic of China
Liu Jiahua
Department of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People’s Republic of China
Zhuang Yingfeng
Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital South Branch, No. 516 Jinrong South Street, Fuzhou, Fujian 350028, People’s Republic of China
Previous work has shown that miR-142-5p in cervical cancer tissues increased significantly compared with adjacent normal tissues. However, the function and the mechanism of miR-142-5p in cervical cancer have not been reported.